OPX-1

Ophthalmic indications for treating the conjunctiva

Morria's MFAIDs have shown preclinical safety and efficacy for treating conjunctivitis and dry eye in animals in studies performed by independent third parties. OPX-1 is a topical treatment (eye drops) targeting inflammation affecting the surface of the eye (conjunctiva) such as Dry Eye Syndrome and allergic conjunctivitis (both seasonal and perennial). MFAIDs have a structure that is particularly attractive for ophthalmological formulation.